A tale of two alleles: TP53 and transformation in MPNs

Antzeko izenburuak

• Molecular characterization of AML‐MRC reveals TP53 mutation as an adverse prognostic factor irrespective of MRC‐defining criteria, TP53 allelic state, or TP53 variant allele frequency
  nork: Davidson Zhao, et al.
  Argitaratua: (2023-03-01)
• MPNs as Inflammatory Diseases: The Evidence, Consequences, and Perspectives
  nork: Hans Carl Hasselbalch, et al.
  Argitaratua: (2015-01-01)
• Mitigating the Risk of t-MNs Development: TP53 or Not TP53?
  nork: Melania Tesio
  Argitaratua: (2023-02-01)
• Philadelphia Negative MPNs, MDS/MPNs and MDS in the Context of Recent WHO Changes and Inclusion of Molecular Signatures into Prognostic Tools: A Single Centre Experience
  nork: Neha Singh, et al.
  Argitaratua: (2023-01-01)
• Cytokine Profiling as a Novel Complementary Tool to Predict Prognosis in MPNs?
  nork: Hans C. Hasselbalch
  Argitaratua: (2020-06-01)